Side Effects and Misconceptions that are Associated with the use of GLP1 Agonists

Learning objectives

Describe the pros and cons of GLP1 receptor agonist use
Effectively communicate and mitigate potential side effects of GLP-1 receptor agonist based medications

Speaker:

Dr. Alice Cheng, MD, FRCPC

Endocrinologist, Trillium Health Partners & Unity Health Toronto
Associate Professor, University of Toronto

Dr. Cheng is an Endocrinologist at Trillium Health Partners and Unity Health Toronto and an Associate Professor at the University of Toronto. She was involved with the development of the Diabetes Canada clinical practice guidelines from 2003 to 2020 and was Chair for the 2013 version. She served as Chair of the Scientific Planning Committee for the 2023 and 2024 American Diabetes Association annual scientific meetings and sits on the planning committee for EASD 2025 and IDF 2025. In addition, she is an Associate Editor for the journal, Diabetes Care, and co-host of the podcast series “Diabetes Care On Air”. In recognition of her contribution to the diabetes community, she has received the 2025 Outstanding Physician Clinician in Diabetes Award from the American Diabetes Association. In addition, she has received the national Charles H. Best Award and the Gerald S. Wong Service Award from Diabetes Canada. She is also the creator of The Med Ed Pledge – an initiative to increase Diversity & Inclusion in continuing medical education (www.theMedEdPledge.com) along with CMEX – a searchable database of health care professionals interested in contributing to medical education.

Back to Main Website Close X